RÉSUMÉ
Hypoxic ischemic encephalopathy (HIE) in neonates can cause severe, life-long functional impairments or death. Treatment of these neonates can involve ethically challenging questions about if, when, and how it may be appropriate to limit life-sustaining medical therapy. Further, parents whose infants suffer severe neurologic damage may seek recourse in the form of a medical malpractice lawsuit. This study uses several hypothetical cases to highlight important ethical and legal considerations in the care of infants with HIE.
Sujet(s)
Hypoxie-ischémie du cerveau , Humains , Hypoxie-ischémie du cerveau/thérapie , Nouveau-né , Faute professionnelle/législation et jurisprudence , Abstention thérapeutique/législation et jurisprudence , Abstention thérapeutique/éthique , Parents , Hypothermie provoquée/éthique , Hypothermie provoquée/méthodesRÉSUMÉ
During the COVID-19 pandemic, institutions developed ventilator allocation models. In one proposed model, neonates compete with adults for ventilators using a scoring system. Points are given for conditions that increase one- and five-year (y) mortality. For example, comparable points were added for adult conditions with mortality of 71.3% and for neonates with moderate or severe bronchopulmonary dysplasia (mod/sBPD). We hypothesized that this model overestimates mortality in neonates with BPD and would penalize these infants unfairly. There was little information available on 1 y and 5 y mortality risk for mod/sBPD. To evaluate this allocation protocol, a retrospective chart review was performed on infants born ≥22 weeks and weighing <1500 g admitted to Rainbow Babies and Children's Hospital in 2015 to identify babies with BPD. The main outcomes were 1 and 5 y mortality. In 2015, 28 infants were diagnosed with mod/s BPD based on NIH 2001 definition; 4 infants had modBPD and 24 had sBPD. All infants (100%) with modBPD survived to 5 y; 2 infants with sBPD died by 1 y (8%) and 22 survived (92%) to 1 y; 3 died (12.5%) by 5 y; and at least 13 survived (54%) to 5 y. Infants with mod/s BPD had lower-than-predicted 1 and 5 y mortality, suggesting the points assigned in the model are too high for these conditions. We believe this model would unfairly penalize these babies.
RÉSUMÉ
Advancements in genetic testing in the healthcare setting, most recently genomic sequencing, has enhanced our ability to diagnose genetic conditions. These advances include increased accessibility and affordability of genomic technologies. With expanded use comes the potential for significant ethical challenges for clinicians, particularly considering the implications of testing a child for one condition and incidentally finding a different condition or health risk. In this focused review, we address various ethical considerations from informed consent to the rights of a child undergoing genetic testing.
Sujet(s)
Dépistage génétique , Consentement libre et éclairé , Humains , Enfant , GénomiqueRÉSUMÉ
Neonatal encephalopathy (NE) is a significant complication of the peripartum period. It can lead to lifelong neurologic disabilities, including cerebral palsy, cognitive impairments, developmental delays, and epilepsy. Induced hypothermia is the first therapy, which has shown promise in improving the outcomes for neonates with moderate to severe NE following a presumed intrapartum insult. NE is also a frequent source of medical malpractice litigation. In this paper, we will review salient features of the American Tort System as it pertains to medical malpractice. We will discuss the obstetric medico-legal implications of therapeutic hypothermia and suggest a five-step approach to analyzing neonatal cases for causation, etiology, timing of occurrence, responsibility, and liability. We will close with three illustrative clinical cases.
Sujet(s)
Asphyxie néonatale , Encéphalopathies , Hypothermie provoquée , Hypoxie-ischémie du cerveau , Faute professionnelle , Asphyxie néonatale/complications , Asphyxie néonatale/thérapie , Encéphalopathies/étiologie , Encéphalopathies/thérapie , Femelle , Humains , Hypoxie-ischémie du cerveau/thérapie , Nouveau-né , Responsabilité légale , GrossesseRÉSUMÉ
Increasing use of social media by patients and clinicians creates opportunities as well as dilemmas for pediatricians, who must recognize the inherent ethical and legal complexity of these communication platforms and maintain professionalism in all contexts. Social media can be a useful tool in the practice of medicine by educating both physicians and patients, expanding access to health care, identifying high-risk behaviors, contributing to research, promoting networking and online support, enhancing advocacy, and nurturing professional compassion. At the same time, there are confidentiality, privacy, professionalism, and boundary issues that need to be considered whenever potential interactions occur between physicians and patients via social media. This clinical report is designed to assist pediatricians in identifying and navigating ethical issues to harness the opportunities and avoid the pitfalls of social media.
Sujet(s)
Pédiatres/éthique , Professionnalisme/éthique , Médias sociaux/éthique , Confidentialité , Conflit d'intérêts , Empathie , Autonomisation , Humains , Relations interpersonnelles , Défense du patient , Éducation du patient comme sujet , Participation des patients , Pédiatres/enseignement et éducation , Relations médecin-patient , Vie privée , Recherche , Prise de risque , Révélation de soiRÉSUMÉ
Despite continued advances and developments in neonatal medicine, neonatal sepsis is the third leading cause of neonatal mortality and a major public health problem, especially in developing countries. Sepsis accounts for mortality for almost 50% of global children under 5 years of age.Over the past 50 years, there have been many advances in the diagnosis, prevention, and treatment of neonatal infections. The diagnostic advances include better culture techniques that permit more rapid confirmation of the diagnosis, advent of polymerase chain reaction (PCR) to rapidly diagnose viral infections, use of biologic markers indicating evidence of infection, and a better understanding of immunoglobulin markers of infection. From a therapeutic stand point, there have been a variety of antibiotics, antifungals, and antiviral agents, better approaches to prevent sepsis, specific immunotherapy, for example, respiratory syncytial virus (RSV); bundled approach to prevention of deep-line infection and better antibiotic stewardship, leading to earlier discontinuation of antibiotic therapy.Hand hygiene remains the benchmark and gold standard for late-onset sepsis prevention. The challenge has been that each decade, newer resistant bacteria dominate as the cause of sepsis and newer viruses emerge, for example, human immunodeficiency virus, zika virus, and novel coronavirus disease 2019.Future treatment options might include stem cell therapy, other antimicrobial protein and peptides, and targeting of pattern recognition receptors in an effort to prevent and/or treat sepsis in this vulnerable population. Also, the microbiome of premature infants has a smaller proportion of beneficial bacteria and higher numbers of pathogenic bacteria compared with term infants, likely owing to higher frequencies of cesarean sections, antibiotic use, exposure to the hospital environment, and feeding nonhuman milk products. Modifying the microbiome with more mother's milk and shorter duration of antibiotics in noninfected babies should be a goal. KEY POINTS: · Neonatal sepsis remains a leading cause of mortality.. · Challenges include bacterial resistance and newer viruses.. · Future treatments may include newer antibiotics/antivirals and stem cell therapy..
Sujet(s)
Antibactériens/usage thérapeutique , Unités de soins intensifs néonatals , Sepsis néonatal/mortalité , Sepsis néonatal/prévention et contrôle , Antiviraux/usage thérapeutique , Résistance bactérienne aux médicaments , Femelle , Humains , Nourrisson , Mortalité infantile , Nouveau-né , Prématuré , Maladies du prématuré/mortalité , Maladies du prématuré/prévention et contrôle , Sepsis néonatal/traitement médicamenteuxRÉSUMÉ
Babies who sustain long term neurologic injury and disability are frequent subjects in medical malpractice litigation. In the United States, the tort system enables adjudication of claims through a proscribed system. This paper will review salient elements of the tort system-duty, breach, causation, and damages- and how they apply to encephalopathic infants whose injuries are believed to be the result of fetal inflammatory response syndrome (FIRS) and/or hypoxic-ischemic damage. FIRS may confound the diagnosis of neonatal encephalopathy but may be a credible explanation for it as well. The ways in which FIRS may impact malpractice lawsuits are presented.
Sujet(s)
Maladies du prématuré/prévention et contrôle , Responsabilité légale , Faute professionnelle/législation et jurisprudence , Prise en charge prénatale/législation et jurisprudence , Syndrome de réponse inflammatoire généralisée/prévention et contrôle , Femelle , Foetus , Humains , Nourrisson , Erreurs médicales/législation et jurisprudence , Grossesse , États-UnisRÉSUMÉ
BACKGROUND: Pediatricians are less frequently sued than other physicians. When suits are successful, however, the average payout is higher. Little is known about changes in the risk of litigation over time. We sought to characterize malpractice lawsuit trends for pediatricians over time. METHODS: The Periodic Survey is a national random sample survey of American Academy of Pediatrics members. Seven surveys between 1987 and 2015 asked questions regarding malpractice (n = 5731). Bivariate and multivariable analyses examined trends and factors associated with risk and outcome of malpractice claims and lawsuits. Descriptive analyses examined potential change in indemnity amount over time. RESULTS: In 2015, 21% of pediatricians reported ever having been the subject of any claim or lawsuit, down from a peak of 33% in 1990. Report of successful outcomes in the most-recent suit trended upward between 1987 and 2015, greatest in 2015 at 58%. Median indemnity was unchanged, averaging $128 000 in 2018 dollars. In multivariate analysis, male sex, hospital-based subspecialty (neonatology, pediatric critical care, pediatric emergency medicine, and hospital medicine), longer career, and more work hours were associated with a greater risk of malpractice claim. CONCLUSIONS: From 1987 to 2015, the proportion of pediatricians sued has decreased and median indemnity has remained unchanged. Male pediatricians and hospital-based subspecialists were more likely to have been sued. Greater knowledge of the epidemiology of malpractice claims against pediatricians is valuable because it can impact practice arrangements, advise risk-management decisions, influence quality and safety projects, and provide data to guide advocacy for appropriate tort reform and future research.
Sujet(s)
Faute professionnelle/tendances , Pédiatrie/tendances , Adulte , Analyse de variance , Compétence clinique/statistiques et données numériques , Femelle , Humains , Mâle , Faute professionnelle/économie , Faute professionnelle/législation et jurisprudence , Faute professionnelle/statistiques et données numériques , Adulte d'âge moyen , Pédiatres/statistiques et données numériques , Pédiatres/tendances , Pédiatrie/économie , Pédiatrie/statistiques et données numériques , Zone exercice professionnel/statistiques et données numériques , Risque , Biais de sélection , Facteurs sexuels , Enquêtes et questionnaires/statistiques et données numériques , États-UnisRÉSUMÉ
Common patient safety issues may result in injuries to babies in the newborn period. A medical malpractice lawsuit is one way in which an injured patient can obtain compensation for the injuries they sustained as the result of an error. There are a number of common areas of malpractice risk for neonatologists including the delivery room, jaundice, hypoglycemia, and late preterm infants. A better understanding of the medical malpractice system and common patient safety issues in neonatology can lead to protective strategies to reduce risk for untoward events and subsequent litigation. Strategies including maintaining competency, following national guidelines, and proper communication and documentation can improve the care and treatment of neonatal patients and their families resulting in less malpractice exposure.
Sujet(s)
Néonatologistes/législation et jurisprudence , Sécurité des patients/législation et jurisprudence , Communication , Accouchement (procédure)/législation et jurisprudence , Documentation , Humains , Hypoglycémie , Nouveau-né , Prématuré , Maladies du prématuré/diagnostic , Maladies du prématuré/thérapie , Ictère néonatal , Responsabilité légale , Faute professionnelle/législation et jurisprudence , Erreurs médicales/législation et jurisprudence , Erreurs médicales/prévention et contrôle , Réanimation , États-UnisRÉSUMÉ
One of the most common dilemmas faced by physicians and genetic counselors is the discovery of misattributed paternity. In this article, we present a case in which misattributed paternity was discovered as an incidental finding. Experts analyze the competing moral obligations that might dictate disclosure or nondisclosure.
Sujet(s)
Conseil génétique/éthique , Dépistage génétique/éthique , Résultats fortuits , Paternité , Révélation de la vérité/éthique , Claudine-1/génétique , Femelle , Conseil génétique/psychologie , Humains , Nouveau-né , Mâle , Jeune adulteSujet(s)
Très grand prématuré , Maladies néonatales , Chine , Prise de décision , Humains , Nourrisson , Nouveau-néRÉSUMÉ
Minor-aged patients are often brought to the pediatrician for nonurgent acute medical care, physical examinations, or health supervision visits by someone other than their legally authorized representative, which, in most situations, is a parent. These surrogates or proxies can be members of the child's extended family, such as a grandparent, adult sibling, or aunt/uncle; a noncustodial parent or stepparent in cases of divorce and remarriage; an adult who lives in the home but is not biologically or legally related to the child; or even a child care provider (eg, au pair, nanny, private-duty nurse/nurse's aide, group home supervisor). This report identifies common situations in which pediatricians may encounter "consent by proxy" for nonurgent medical care for minors, including physical examinations, and explains the potential for liability exposure associated with these circumstances. The report suggests practical steps that balance the need to minimize the physician's liability exposure with the patient's access to health care. Key issues to be considered when creating or updating office policies for obtaining and documenting consent by proxy are offered.
Sujet(s)
Responsabilité légale , Pédiatrie/législation et jurisprudence , Mandataire/législation et jurisprudence , Consentement d'un tiers/législation et jurisprudence , Adolescent , Enfant , Garde d'enfant/législation et jurisprudence , Confidentialité/législation et jurisprudence , Documentation , Accessibilité des services de santé/législation et jurisprudence , Humains , Consentement libre et éclairé/législation et jurisprudence , Tuteurs légaux/législation et jurisprudence , Consultation médicale , Facteurs de risque , Sociétés médicales , États-UnisRÉSUMÉ
For parents, the experience of having an infant in the NICU is often psychologically traumatic. No parent can be fully prepared for the extreme stress and range of emotions of caring for a critically ill newborn. As health care providers familiar with the NICU, we thought that we understood the impact of the NICU on parents. But we were not prepared to see the children in our own families as NICU patients. Here are some of the lessons our NICU experience has taught us. We offer these lessons in the hope of helping health professionals consider a balanced view of the NICU's impact on families.
Sujet(s)
Attitude du personnel soignant , Unités de soins intensifs néonatals , Parents/psychologie , Maladie grave/psychologie , Émotions , Humains , Nourrisson , Nouveau-né , Relations famille-professionnel de santé , Résilience psychologique , Stress psychologique/étiologieRÉSUMÉ
UNLABELLED: Despite extensive use of the term 'standard of care' (SOC), there is no such medical definition. How are neonatal therapies accepted as SOC with huge centre-to-centre variation? What defines SOC? We will consider paths to acceptance of multiple therapies (antenatal corticosteroids, preventing GBS, others). We conclude single-centre trials drive care, but are not consistently predictive for multicentre trials. Innovation/quality improvement initiatives also alter care, despite strong evidence practice changes take time. Furthermore, there are powerful medico-legal implications if a therapy is designated SOC. CONCLUSION: Defining SOC is a quandary with more legal implications than medical, but what's most critical is keeping current in a rapidly changing field.